Page 6 - Presentation
P. 6

Learning Objectives










        By the end of this program, participants will be able to:


        • Assess and recognize patients with metastatic castration-sensitive prostate cancer
            (mCSPC), non-metastatic castration-resistant prostate cancer (nmCRPC), and

            metastatic castration-resistant prostate cancer (mCRPC) who require an intensification
            or change in their treatment strategy


        • Integrate recent Canadian guidance for the management of advanced prostate cancer
            into routine practice


        • Facilitate patient referral from community practices to tertiary centres as appropriate for

            patients with advanced disease to access the appropriate therapies and services






                                                                                                                                              7 7 7
   1   2   3   4   5   6   7   8   9   10   11